# Duration of Benefit for OnabotulinumtoxinA in Treatment of Chronic Migraine

> **NCT02037425** · PHASE4 · COMPLETED · sponsor: **Cady, Roger, M.D.** · enrollment: 44 (actual)

## Conditions studied

- Chronic Migraine

## Interventions

- **DRUG:** onabotulinumtoxinA

## Key facts

- **NCT ID:** NCT02037425
- **Lead sponsor:** Cady, Roger, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2016-08-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02037425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02037425, "Duration of Benefit for OnabotulinumtoxinA in Treatment of Chronic Migraine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02037425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*